Answers are grounded in this paper and cite their sources.
Retrospective longitudinal analysis reveals pulmonary function decline in stable systemic sclerosis cases, suggesting clinical implications.
Baseline DLco/SB <70% is a potential marker of disease progression in VEDOSS; however, subtle progressive pulmonary function decline may occur even in stable patients.
No takes yet. Share an insight, caveat, or question.
Capparelli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: